DI TRANA, ANNAGIULIA
 Distribuzione geografica
Continente #
NA - Nord America 572
EU - Europa 222
AS - Asia 79
Totale 873
Nazione #
US - Stati Uniti d'America 571
IT - Italia 79
SE - Svezia 50
CN - Cina 48
IE - Irlanda 48
SG - Singapore 17
GB - Regno Unito 13
DE - Germania 12
UA - Ucraina 6
GE - Georgia 5
IN - India 5
FR - Francia 3
BE - Belgio 2
FI - Finlandia 2
MK - Macedonia 2
NL - Olanda 2
TR - Turchia 2
AT - Austria 1
CA - Canada 1
CH - Svizzera 1
KR - Corea 1
PH - Filippine 1
PL - Polonia 1
Totale 873
Città #
Chandler 119
Des Moines 82
Fairfield 49
Dublin 48
Ashburn 35
Seattle 22
Woodbridge 17
Cambridge 16
Turin 15
Wilmington 15
Houston 14
Lawrence 14
Princeton 14
Boardman 13
Jacksonville 13
Ancona 12
Ann Arbor 8
Los Angeles 8
San Mateo 8
Miami Beach 7
Washington 7
Cagliari 6
Boydton 5
Centro 5
Shenzhen 5
Tbilisi 5
Tolentino 5
New York 4
Pune 4
Rome 4
Shanghai 4
Beijing 3
Freiburg im Breisgau 3
Guangzhou 3
London 3
San Diego 3
Southwark 3
Amsterdam 2
Arbroath 2
Bitola 2
Brussels 2
Carisio 2
Chengdu 2
Civitanova Marche 2
Huntingdon Valley 2
Istanbul 2
Jinhua 2
Porto Sant'elpidio 2
Umbertide 2
Wandsworth 2
Wuhan 2
Bacolod City 1
Bologna 1
Dallas 1
Falconara Marittima 1
Falls Church 1
Fuzhou 1
Helsinki 1
Islington 1
Jiaxing 1
Kazmierz 1
Kilburn 1
Kolkata 1
Lianyun 1
Margate 1
Medford 1
Monsampolo del Tronto 1
Nanjing 1
New Bedfont 1
Norwalk 1
Potomac 1
Quanzhou 1
Rahway 1
Redwood City 1
Resana 1
Seoul 1
Singapore 1
Suzhou 1
Vienna 1
Villongo 1
Yiwu 1
Totale 659
Nome #
Biomedical analysis of New Psychoactive Substances (NPS) of natural origin 92
Is etizolam a safe medication? Effects on psychomotor perfomance at therapeutic dosages of a newly abused psychoactive substance 85
Disposition of cannabidiol metabolites in serum and urine from healthy individuals treated with pharmaceutical preparations of medical cannabis 75
A Review of Synthetic Cathinone-Related Fatalities From 2017 to 2020 74
Monitoring Prenatal Exposure to Buprenorphine and Methadone 69
Profiling of in vitro metabolism of New Psychoactive Substances 66
Testing Unconventional Matrices to Monitor for Prenatal Exposure to Heroin, Cocaine, Amphetamines, Synthetic Cathinones, and Synthetic Opioids 65
A comprehensive HPLC–MS-MS screening method for 77 new psychoactive substances, 24 classic drugs and 18 related metabolites in blood, urine and oral fluid 60
Development and validation of fast UHPLC-MS/MS screening method for 87 NPS and 32 other drugs of abuse in hair and nails: application to real cases 60
In silico prediction, LC-HRMS/MS analysis, and targeted/untargeted data-mining workflow for the profiling of phenylfentanyl in vitro metabolites 41
3F-α-pyrrolydinovalerophenone (3F-α-PVP) in vitro human metabolism: Multiple in silico predictions to assist in LC-HRMS/MS analysis and targeted/untargeted data mining 39
Consequences of COVID-19 Lockdown on the Misuse and Marketing of Addictive Substances and New Psychoactive Substances 37
Commentary: Tele-COVID-19: Does it improve the provision of health services? 26
Adulterants in drugs of abuse: a recent focus of a changing phenomenon 26
Disposition of Hexahydrocannabinol Epimers and Their Metabolites in Biological Matrices following a Single Administration of Smoked Hexahydrocannabinol: A Preliminary Study 17
β'-Phenylfentanyl Metabolism in Primary Human Hepatocyte Incubations: Identification of Potential Biomarkers of Exposure in Clinical and Forensic Toxicology 16
The first LC-MS/MS stereoselective bioanalytical methods to quantitatively detect 9R- and 9S-hexahydrocannabinols and their metabolites in human blood, oral fluid and urine 12
Molecular Insights and Clinical Outcomes of Drugs of Abuse Adulteration: New Trends and New Psychoactive Substances 9
Sweat Testing for the Detection of Methylone after Controlled Administrations in Humans 6
Liquid Chromatography High-Resolution Mass Spectrometry in Forensic Toxicology: What are the Specifics of Method Development, Validation and Quality Assurance for Comprehensive Screening Approaches? 6
The new synthetic benzimidazole opioid etonitazepipne: an emerging fatal harm and a challenge for laboratory medicine 6
null 5
Analysis of perfluoroalkyl substances ({PFAS}) in conventional and unconventional matrices: Clinical outcomes 4
Synthetic Benzimidazole Opioids: The Emerging Health Challenge for European Drug Users 4
“Tranq-dope”: The first fatal intoxication due to xylazine-adulterated heroin in Italy 4
Editorial: Psychiatric and Pharmacotoxicological Insights on Appearance and Performance Enhancing Drugs 4
Editorial: Drug-drug interactions in pharmacology 3
Liquid chromatography in forensic toxicology 3
Molecular Insights of New Psychoactive Substances (NPS) 2.0 3
Target Analysis of NPS in Oral Fluid 2
Comprehensive Monitoring of Psychoactive Substances in Psychiatric Patients Using Liquid Chromatography-High-Resolution Mass Spectrometry: A Key Tool for Treatment Planning and Understanding Consumption Patterns in Rome, Italy. 2
Hexahydrocannabinol Pharmacology, Toxicology, and Analysis: The First Evidence for a Recent New Psychoactive Substance 1
The targeted analysis of New Psychoactive Substances in oral fluid through chromatographic-spectrometric methods: review of recent findings 1
The importance of updatable analytical screening methods for new psychoactive substances in clinical and forensic toxicology 1
Totale 924
Categoria #
all - tutte 6.220
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.220


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202014 0 0 0 0 0 2 2 0 2 0 4 4
2020/2021155 5 2 6 1 2 18 32 1 25 16 24 23
2021/2022100 2 11 4 0 0 7 4 6 10 12 16 28
2022/2023378 29 40 21 20 19 113 1 24 71 0 31 9
2023/2024242 34 4 27 23 33 26 7 17 4 10 17 40
2024/202535 35 0 0 0 0 0 0 0 0 0 0 0
Totale 924